List of 27 pharmaceuticals available through GHS and for a long time present shortage in private pharmacies or, while provided through GHS and in stock, are only available for purchase outside of GHS, is attached in a letter to the Chairman of the Board of Directors of the Health Insurance Agency, the Chairman of the Parliamentary Health Committee and Vice President of DISY Efthimios Diplaros.
The letter was submitted before the Parliamentary Health Committee.
As Mr Diplaros told the Cyprus Times, the action follows relevant complaints which are forwarded to the OAI in order to study the issue, "which touches on the quality of health services provided, but mainly on the dignified treatment of chronic patients by the state", as stated in the letter.
"At the same time, a number of medicines, necessary for the treatments of mainly chronic patients, are not available within the General Health Insurance Fund or are available at a high cost of supplementation for the beneficiary", says the letter of Efthymios Diplaros.
OAI is invited to inform the Parliamentary Health Committee on the issue, as well as on the possible actions that the Health Insurance Agency intends to take in order to address the problem.
"Recognizing the remarkable work that the Health Insurance Agency is doing to improve the health services provided within the GHS, the Parliamentary Health Committee is confident that you will address the issue raised in this letter."
Below is the list of drugs:
HTTPS:/CYPRUSTIMES.COM/WP-CONTENT/UPLOADS/2022/03/SCREENHUNTER-10.PNG HTTPS:/CYPRUSTIMES.COM/WP-CONTENT/UPLOADS/2022/03/SCREENHUNTER-11.PNG HTTPS:/CYPRUSTIMES.COM/WP-CONTENT/UPLOADS/2022/03/SCREENHUNTER-12.PNG
Contents of this article including associated images are belongs Cyprus Times
Views & opinions expressed are those of the author and/or Cyprus Times
Source
